Are you Stephen Harnicar?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 2 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Hospital Affiliations
- Memorial Sloan Kettering Cancer CenterNew York, New York
Education & Training
- Duquesne UniversityPharmD, 2006
Publications & Presentations
PubMed
- 66 citationsEntrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of NTRK, ROS1, and ALK fusion-positive solid tumors.Dazhi Liu, Michael Offin, Stephen Harnicar, Bob T. Li, Alexander Drilon> ;Therapeutics and Clinical Risk Management. 2018 Jul 20
- 35 citationsRivaroxaban for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation and Active Cancer.Eva S. Laube, Anthony F. Yu, Dipti Gupta, Yimei Miao, Patrick Samedy, Jonathan Wills, Stephen Harnicar, Gerald A. Soff, Simon Mantha> ;The American Journal of Cardiology. 2017 Jul 15
- Pharmacotherapy for chronic myelogenous leukemia: a case-based approach.Harnicar, S.> ;Journal of the National Comprehensive Cancer Network : JNCCN. 2011 May 20
Office
1275 York Ave
New York, NY 10065Phone+1 212-639-6227- Is this information wrong?